Increase amlodipine to 10 mg daily
The next step is to increase amlodipine from 2.5 mg to 10 mg daily, as this patient is on a suboptimal dose of a calcium channel blocker in their current three-drug regimen.
Current Regimen Analysis
This patient is on a standard triple-therapy combination (ARB + thiazide diuretic + calcium channel blocker), but the amlodipine dose is significantly below target:
- Losartan 100 mg: Maximum dose achieved 1
- HCTZ 25 mg: Maximum dose achieved 1
- Amlodipine 2.5 mg: Well below the therapeutic range
The FDA label for amlodipine clearly states that the usual initial dose is 5 mg daily with a maximum of 10 mg daily 2. The current 2.5 mg dose is only recommended for "small, fragile, or elderly patients, or patients with hepatic insufficiency" 2. Unless this patient fits these specific criteria, they are undertreated.
Guideline-Based Approach
The 2020 ISH guidelines provide a clear stepwise algorithm for uncontrolled hypertension 3:
For non-Black patients:
- Low dose ACE/ARB
- Add DHP-CCB
- Increase to full dose
- Add thiazide/thiazide-like diuretic
- Add spironolactone (or alternatives)
This patient has completed steps 1,2, and 4, but has skipped step 3 (increasing to full dose). Before adding a fourth agent, all three current medications should be optimized to their maximum tolerated doses.
Dosing Rationale
- Amlodipine 5-10 mg is the effective therapeutic range for hypertension 2
- Most patients require 10 mg for adequate BP control 2
- The 2024 ESC guidelines emphasize maximizing doses of existing medications before adding new agents 4
- Titration should occur over 7-14 days, with more rapid titration if clinically warranted 2
Implementation Strategy
- Increase amlodipine to 5 mg daily immediately
- Reassess BP in 1-2 weeks
- If still uncontrolled, increase to 10 mg daily
- Reassess at 4 weeks (amlodipine reaches steady state in 7-8 days)
If Still Uncontrolled After Optimization
Only after maximizing amlodipine to 10 mg daily should you consider:
Step 4: Add spironolactone (first-line fourth agent per ISH 2020 and AHA 2018 guidelines 3, 5):
- Start 25 mg daily
- Check potassium and renal function within 1 week
- Contraindicated if K+ >5.0 mEq/L or eGFR <30 mL/min
Alternatives if spironolactone contraindicated 3, 5:
- Amiloride
- Doxazosin
- Eplerenone
- Beta-blocker (if compelling indication like CAD or heart failure)
- Clonidine (less preferred)
Critical Pitfalls to Avoid
- Don't add a fourth drug before optimizing the third: This is polypharmacy without maximizing existing therapy
- Don't assume resistance prematurely: True resistant hypertension requires three optimally dosed medications including a diuretic 5
- Check medication adherence: Before escalating, confirm the patient is actually taking all three medications 3, 5, 6
- Confirm with home BP monitoring: Rule out white-coat hypertension (target <135/85 mmHg at home) 3
- Screen for secondary causes: Especially if BP remains uncontrolled after proper four-drug therapy 5
Special Considerations
The 2018 AHA statement on resistant hypertension emphasizes that proper evaluation requires all three drugs at maximum tolerated doses 5. The current regimen doesn't meet this criterion because amlodipine is at 25% of maximum dose.